Marquest Medical Products Inc. Announces Leadership Changes

Strategic Insights

Feb 26, 1995 — 1 min read

The board of directors at Marquest Medical Products Inc. (Nasdaq: MMPI) has undergone significant changes, with James E. Brands, Robert D. Tucker, and Denise C. Demick submitting their resignations as board members. Brands and Demick have also resigned as Chairman and Chief Executive Officer and as Secretary, respectively. Robert P. Scherer Jr. has been appointed as the new Chairman and Chief Executive Officer, while Margaret Von der Schmidt will take over as Secretary. William J. Thompson continues to serve as President, Chief Operating Officer, and Director. The board has also named Steven Lukas Sr. and Kenneth H. Robertson as new directors, joining Robert P. Scherer Jr.

Key Takeaways:

Three board members, James E. Brands, Robert D. Tucker, and Denise C. Demick, have resigned from Marquest Medical Products Inc.
Robert P. Scherer Jr. has been appointed as the new Chairman and Chief Executive Officer, replacing James E. Brands.
Margaret Von der Schmidt will take over as Secretary, replacing Denise C. Demick.
William J. Thompson continues to serve as President, Chief Operating Officer, and Director.
Two new directors, Steven Lukas Sr. and Kenneth H. Robertson, have been appointed to replace the resigning directors.
Robert P. Scherer Jr. has extensive experience in the pharmaceutical industry, including 20 years as Chairman, President, and Chief Executive Officer of R. P. Scherer Corporation.
Steven Lukas Sr. has international experience with IVAX Corporation and previously held positions with Parke-Davis and R. P. Scherer Corporation.
Kenneth H. Robertson is the founder of Conference Call U.S.A. and has expertise in the call center industry.

Statistics:

Marquest Medical Products Inc. is an international manufacturer and distributor of disposable devices for cardiopulmonary support, respiratory, and anesthesia.
The company has undergone significant leadership changes, with three board members resigning and two new directors being appointed.
Robert P. Scherer Jr. has 20 years of experience in the pharmaceutical industry.

Sources:

PRNewswire, 2/27/95
Marquest Medical Products Inc. press release, 2/27/95

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients